Tumor Necrosis Factor-α in Human American Tegumentary Leishmaniasis

Memorias do Instituto Oswaldo Cruz

Volumn 91, Issue 2, 1996, Pages 225-229

  Da Cruz, Alda Maria ^a   De Oliveira, Márcia Pereira ^a   De Luca, Paula Mello ^a   Mendonça, Sergio C F ^a   Coutinho, Sergio G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cytokine; Leishmania braziliensis; Tegumentary leishmaniasis; TNF

Indexed keywords

LEISHMANIA BRAZILIENSIS;

PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; FOLLOW UP; HUMAN; IMMUNOLOGY; LEISHMANIA BRAZILIENSIS; MIDDLE AGED; PHYSIOLOGY; SKIN LEISHMANIASIS; SKIN TEST;

ADULT; ANIMALS; ANTIGENS, PROTOZOAN; FOLLOW-UP STUDIES; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MIDDLE AGED; SKIN TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030091589     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761996000200019     Document Type: Article

References (30)

1. Ayehunie S, Sonnerborg A, Yemane-Berhan T, Zewdie DW, Britton S, Strannegard O 1993. Raised levels of tumour necrosis factor-alpha and neopterin, but not interfcron-alpha, in serum of HIV-1-infected patients from Ethiopia. Clin Exp Immunol 91: 37-42.
2. Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL 1992. Tumor necrosis factor production in patients with leprosy. Infect Immun 60: 1441-1446.
3. Barral-Neto M, Badaró R, Barral A, Almeida RP, Santos SB, Badaró F, Pedral-Sampaio D, Carvalho EM, Falcoff E, Falcoff R 1991. Tumor necrosis factor in human visceral leishmaniasis. J Infect Dis 163: 853-857.
4. Beutler B, Cerami A 1988. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Ann Rev Biochem 57: 505-518.
5. + T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J Leu Biol 51: 296-299.
6. Bryceson ADM 1970. Diffuse cutaneous leishmaniasis in Ethiopia III. Immunological studies. Trans R Soc Trop Med Hyg 64: 380-393.
7. Cáceres-Dittmar G, Tapia FJ, Sánchez MA, Yamamura M, Uyemura K, Modlin RL, Bloom BR, Convit J 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using polymerase chain reaction. Clin Exp Immunol 91: 500-505.
8. Camussi G, Albano E, Tetta C, Bussolino F 1991. The molecular action of tumor necrosis factor-α. Eur J Biochem 202. 3-14.
9. Carvalho EM, Bacellar O, Reed SG, Barrai A, Rocha H 1988. Visceral leishmaniasis: a disease associated with inability of lymphocyte to activate macrophage to kill Letshmania. Braz J Med Biol Res 21: 85-92.
10. Conceição-Silva F, Dórea RCC, Pirmez C, Schubach A, Coutinho SG 1990. Quantitative study of Leishmama braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis. Clin Exp Immunol 79: 221-226.
11. Coutinho SG, Pirmez C, Mendonça SCF, Conceição-Silva F, Dórea RCC 1987. Pathogenesis and immunopathology of leishmaniasis. Mem Inst Oswaldo Cruz 82: 214-228.
12. Glimaker M, Kragsbjerg P, Forsgren M, Olcén P 1993. Tumor necrosis factor-α (TNFα) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNFα indicate bacterial meningitis. J Infect Dis 167: 882-889.
13. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
14. Grimaldi Jr G, Momen H, Naiff RD, McMahon-Pratt D, Barrett TV 1991. Characterization and classification of leishmanial parasites from humans, wild mammals and sand flies in the Amazon region of Brazil. Am J Trop Med Hyg 44: 645-661.
15. Hackett SP, Stevens DL 1992. Streptococcal toxic shock syndrome synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 165: 879-885.
16. Kriegler M, Perez C, DeFay K, Albert I, Lu SD 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for complex physiology of TNF. Cell 53: 45-53.
17. Leroux-Roels G, Offner F, Philippé J, Vermeulen A 1988 Influence of blood-collecting systems on concentrations of tumor necrosis factor in serum and plasma. Clin Chem 34: 2373-2374.
18. Liew FY, Li Y, Millott S 1990a. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145: 4306-4310.
19. Liew FY, Li Y, Yang DM, Severn A, Cox FEG 1991. TNF-α reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis. Immunol 74: 304-309.
20. Liew FY, Parkinson C, Millott S, Severn A, Carrier M 1990b. Tumor necrosis factor (TNFα) in leishmaniasis. I. TNFα mediates host protection against cutaneous leishmaniasis. Immunol 69: 570-573.
21. Nicolle MC 1908. Culture du parasite du bouton d'Orient. C R Acad Sci 146: 842-843.
22. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F, Modlin RL 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91: 1390-1395.
23. Pisa P, Gennene M, Söder O, Ottenhoff T, Hansson M, Kiessling R 1990. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis 161: 988-991.
24. Sarno EN, Grau GE, Vieira LMM, Nery JA 1991. Serum levels of tumour necrosis factor-alpha and interleukin-1β during leprosy reactional states. Clin Exp Immunol 84: 103-108.
25. Sung S-SJ, Bjorndahl JM, Wang CY, Kao HT, Fu SM 1988. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med 167: 937-953.
26. Suputtamongkol Y, Kwiatkowski D, Dance DAB, Chaowagul W, White NJ 1992. Tumor necrosis factor in septicemic melioidosis. J Infect Dis 165: 561-564.
27. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR 1992. Measuring cytokine levels in blood. Importance of anticoagulants, processing and storage conditions. J Immunol Methods 153: 115-124.
28. Titus RG, Sherry B, Cerami A 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 170: 2097-2104.
29. Vassalli P 1992. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411-452.
30. Waage A, Halstensen A, Espevik T 1987. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet I: 355-357.